McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a May 19, 2017 edition of Bloomberg BNA’s Life Sciences Law & Industry Report in an article entitled, “Proposals Stress Need to Change Patent Eligibility Law.” Proposals to amend the patent law to address perceived roadblocks to biopharma innovation may not succeed as written but emphasize the need to change the law, attorneys told Bloomberg BNA. View the article